Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4)

Gene Therapy volume 12, pages 418–426 (2005)Cite this article

Abstract

Gene therapy approaches to bone tissue engineering have been widely explored. While localized delivery of plasmid DNA encoding for osteogenic factors is attractive for promoting bone regeneration, the low transfection efficiency inherent with plasmid delivery may limit this approach. We hypothesized that this limitation could be overcome by condensing plasmid DNA with nonviral vectors such as poly(ethylenimine) (PEI), and delivering the plasmid DNA in a sustained and localized manner from poly(lactic-co-glycolic acid) (PLGA) scaffolds. To address this possibility, scaffolds delivering plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4) were implanted into a cranial critical-sized defect for time periods up to 15 weeks. The control conditions included no scaffold (defect left empty), blank scaffolds (no delivered DNA), and scaffolds encapsulating plasmid DNA (non-condensed). Histological and microcomputed tomography analysis of the defect sites over time demonstrated that bone regeneration was significant at the defect edges and within the defect site when scaffolds encapsulating condensed DNA were placed in the defect. In contrast, bone formation was mainly confined to the defect edges within scaffolds encapsulating plasmid DNA, and when blank scaffolds were used to fill the defect. Histomorphometric analysis revealed a significant increase in total bone formation (at least 4.5-fold) within scaffolds incorporating condensed DNA, relative to blank scaffolds and scaffolds incorporating uncondensed DNA at each time point. In addition, there was a significant increase both in osteoid and mineralized tissue density within scaffolds incorporating condensed DNA, when compared with blank scaffolds and scaffolds incorporating uncondensed DNA, suggesting that delivery of condensed DNA led to more complete mineralized tissue regeneration within the defect area. This study demonstrated that the scaffold delivery system encapsulating PEI-condensed DNA encoding for BMP-4 was capable of enhancing bone formation and may find applications in other tissue types.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Goldstein SA, Patil PV, Moalli MR . Perspectives on tissue engineering of bone. Clin Orthop 1999; (Suppl 367): S419–S423.

    Article  Google Scholar 

  2. Crane GM, Ishaug SL, Mikos AG . Bone tissue engineering. Nat Med 1995; 1: 1322–1324.

    Article  CAS  Google Scholar 

  3. Calvert JW, Weiss LE, Sundine MJ . New frontiers in bone tissue engineering. Clin Plast Surg 2003; 30: 641–648.

    Article  Google Scholar 

  4. Constantz BR et al. Skeletal repair by in situ formation of the mineral phase of bone. Science 1995; 267: 1796–1799.

    Article  CAS  Google Scholar 

  5. Petite H et al. Tissue-engineered bone regeneration. Nat Biotechnol 2000; 18: 959–963.

    Article  CAS  Google Scholar 

  6. Vacanti CA, Upton J . Tissue-engineered morphogenesis of cartilage and bone by means of cell transplantation using synthetic biodegradable polymer matrices. Clin Plast Surg 1994; 21: 445–462.

    CAS  PubMed  Google Scholar 

  7. Lane JM, Bostrom MP . Bone grafting and new composite biosynthetic graft materials. Instr Course Lect 1998; 47: 525–534.

    CAS  PubMed  Google Scholar 

  8. Lane JM, Tomin E, Bostrom MP . Biosynthetic bone grafting. Clin Orthop 1999; (Suppl 367): S107–S117.

    Article  Google Scholar 

  9. Cao Y, Ibarra C, Vacanti CA . Tissue engineering cartilage and bone. In: Mooney D (ed). Synthetic Biodegradable Polymer Scaffolds. Birkhauser: Boston, 1997, pp 199–214.

    Chapter  Google Scholar 

  10. Fang J et al. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci USA 1996; 93: 5753–5758.

    Article  CAS  Google Scholar 

  11. Bonadio J, Smiley E, Patil P, Goldstein S . Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med 1999; 5: 753–759.

    Article  CAS  Google Scholar 

  12. Kirker-Head CA . Potential applications and delivery strategies for bone morphogenetic proteins. Adv Drug Deliv Rev 2000; 43: 65–92.

    Article  CAS  Google Scholar 

  13. Krebsbach PH, Gu K, Franceschi RT, Rutherford RB . Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo. Hum Gene Ther 2000; 11: 1201–1210.

    Article  CAS  Google Scholar 

  14. Shea LD, Smiley E, Bonadio J, Mooney DJ . DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol 1999; 17: 551–554.

    Article  CAS  Google Scholar 

  15. Shea LD, Wang D, Franceschi RT, Mooney DJ . Engineered bone development from a pre-osteoblast cell line on three-dimensional scaffolds. Tissue Eng 2000; 6: 605–617.

    Article  CAS  Google Scholar 

  16. Ohgushi H, Caplan AI . Stem cell technology and bioceramics: from cell to gene engineering. J Biomed Mater Res 1999; 48: 913–927.

    Article  CAS  Google Scholar 

  17. Burg KJ, Porter S, Kellam JF . Biomaterial developments for bone tissue engineering. Biomaterials 2000; 21: 2347–2359.

    Article  CAS  Google Scholar 

  18. Griffith LG, Naughton G . Tissue engineering—current challenges and expanding opportunities. Science 2002; 295: 1009–1014.

    Article  CAS  Google Scholar 

  19. Bonadio J . Tissue engineering via local gene delivery: update and future prospects for enhancing the technology. Adv Drug Deliv Rev 2000; 44: 185–194.

    Article  CAS  Google Scholar 

  20. Olmsted EA et al. Adenovirus-mediated BMP2 expression in human bone marrow stromal cells. J Cell Biochem 2001; 82: 11–21.

    Article  CAS  Google Scholar 

  21. Chen Y et al. Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors. Gene Therapy 2003; 10: 1345–1353.

    Article  CAS  Google Scholar 

  22. Laurencin CT et al. Poly(lactide-co-glycolide)/hydroxyapatite delivery of BMP-2-producing cells: a regional gene therapy approach to bone regeneration. Biomaterials 2001; 22: 1271–1277.

    Article  CAS  Google Scholar 

  23. Olmsted-Davis EA et al. Use of a chimeric adenovirus vector enhances BMP2 production and bone formation. Hum Gene Ther 2002; 13: 1337–1347.

    Article  CAS  Google Scholar 

  24. Sakou T . Bone morphogenetic proteins: from basic studies to clinical approaches. Bone 1998; 22: 591–603.

    Article  CAS  Google Scholar 

  25. Linkhart TA, Mohan S, Baylink DJ . Growth factors for bone growth and repair: IGF, TGF beta and BMP. Bone 1996; 19: 1S–12S.

    Article  CAS  Google Scholar 

  26. Dayoub H et al. Human mesenchymal stem cells transduced with recombinant bone morphogenetic protein-9 adenovirus promote osteogenesis in rodents. Tissue Eng 2003; 9: 347–356.

    Article  CAS  Google Scholar 

  27. Bonadio J, Goldstein SA, Levy RJ . Gene therapy for tissue repair and regeneration. Adv Drug Deliv Rev 1998; 33: 53–69.

    Article  CAS  Google Scholar 

  28. Deckers MM et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 2002; 143: 1545–1553.

    Article  CAS  Google Scholar 

  29. Akino K, Mineta T, Fukui M, Akita S . P-II-04 early phase regulation of human mesenchymal stem cells and the unique profile of the proliferation by bone morphogenetic protein-2. Wound Repair Regen 2004; 12: A6.

    Article  Google Scholar 

  30. Akino K et al. Bone morphogenetic protein-2 regulates proliferation of human mesenchymal stem cells. Wound Repair Regen 2003; 11: 354–360.

    Article  Google Scholar 

  31. Reddi AH . Bone morphogenetic proteins, bone marrow stromal cells, and mesenchymal stem cells. Maureen Owen revisited. Clin Orthop 1995; (313): 115–119.

  32. Dumont RJ et al. Ex vivo bone morphogenetic protein-9 gene therapy using human mesenchymal stem cells induces spinal fusion in rodents. Neurosurgery 2002; 51: 1239–1244; discussion 1244–1245.

    Article  Google Scholar 

  33. Gysin R et al. Ex vivo gene therapy with stromal cells transduced with a retroviral vector containing the BMP4 gene completely heals critical size calvarial defect in rats. Gene Therapy 2002; 9: 991–999.

    Article  CAS  Google Scholar 

  34. Kay MA, Liu D, Hoogerbrugge PM . Gene therapy. Proc Natl Acad Sci USA 1997; 94: 12744–12746.

    Article  CAS  Google Scholar 

  35. Romano G, Micheli P, Pacilio C, Giordano A . Latest developments in gene transfer technology: achievements, perspectives, and controversies over therapeutic applications. Stem Cells 2000; 18: 19–39.

    Article  CAS  Google Scholar 

  36. Helm GA et al. Utilization of type I collagen gel, demineralized bone matrix, and bone morphogenetic protein-2 to enhance autologous bone lumbar spinal fusion. J Neurosurg 1997; 86: 93–100.

    Article  CAS  Google Scholar 

  37. Li SH, De Wijn JR, Layrolle P, de Groot K . Synthesis of macroporous hydroxyapatite scaffolds for bone tissue engineering. J Biomed Mater Res 2002; 61: 109–120.

    Article  CAS  Google Scholar 

  38. Whang K et al. Ectopic bone formation via rhBMP-2 delivery from porous bioabsorbable polymer scaffolds. J Biomed Mater Res 1998; 42: 491–499.

    Article  CAS  Google Scholar 

  39. Marra KG et al. In vitro analysis of biodegradable polymer blend/hydroxyapatite composites for bone tissue engineering. J Biomed Mater Res 1999; 47: 324–335.

    Article  CAS  Google Scholar 

  40. Lunsford L, McKeever U, Eckstein V, Hedley ML . Tissue distribution and persistence in mice of plasmid DNA encapsulated in a PLGA-based microsphere delivery vehicle. J Drug Target 2000; 8: 39–50.

    Article  CAS  Google Scholar 

  41. Ando S, Putnam D, Pack DW, Langer R . PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. J Pharm Sci 1999; 88: 126–130.

    Article  CAS  Google Scholar 

  42. Boussif O et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 1995; 92: 7297–7301.

    Article  CAS  Google Scholar 

  43. Huang YC et al. Fabrication and in vitro testing of polymeric delivery system for condensed DNA. J Biomed Mater Res 2003; 67A: 1384–1392.

    Article  CAS  Google Scholar 

  44. Winn SR et al. Tissue-engineered bone biomimetic to regenerate calvarial critical-sized defects in athymic rats. J Biomed Mater Res 1999; 45: 414–421.

    Article  CAS  Google Scholar 

  45. Hollinger JO, Kleinschmidt JC . The critical size defect as an experimental model to test bone repair materials. J Craniofac Surg 1990; 1: 60–68.

    Article  CAS  Google Scholar 

  46. Huang YC, Rice KG, Mooney DJ . Long-term in vivo gene expression via delivery of PEI-DNA condensates from porous polymer scaffolds. Hum Gene Ther (in press).

  47. Opperman LA . Cranial sutures as intramembranous bone growth sites. Dev Dyn 2000; 219: 472–485.

    Article  CAS  Google Scholar 

  48. Wozney JM, Rosen V . Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop 1998; (346): 26–37.

    Article  Google Scholar 

  49. Turunen MP et al. Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer–plasmid complexes. Gene Therapy 1999; 6: 6–11.

    Article  CAS  Google Scholar 

  50. Harris LD, Kim BS, Mooney DJ . Open pore biodegradable matrices formed with gas foaming. J Biomed Mater Res 1998; 42: 396–402.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Financial support for this work was provided by the National Institute of Health Grant RO1DE13004 and the US Army Research Laboratory and the US Army Research Office under Grant Number DAAD190310168. We thank the Bone Center (NIH5P30AR46024) at the University of Michigan for assistance in micro-CT analysis, and gratefully acknowledge technical assistance from Ryan Frank.

Author information

Authors and Affiliations

  1. Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA

    Y-C Huang, C Simmons & D J Mooney

  2. Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, USA

    D J Mooney

  3. Department of Biologic & Materials Sciences, University of Michigan, Ann Arbor, MI, USA

    C Simmons, D Kaigler & D J Mooney

  4. College of Pharmacy, University of Iowa, Iowa City, IA, USA

    K G Rice

Authors
  1. Y-C Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C Simmons
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D Kaigler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K G Rice
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D J Mooney
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, YC., Simmons, C., Kaigler, D. et al. Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4). Gene Ther 12, 418–426 (2005). https://doi.org/10.1038/sj.gt.3302439

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302439

Keywords

This article is cited by

Search

Advanced search

Quick links